top of page

 
業績|論文・出版物|目次|ALL
 

Downregulation of human CD46 by adenovirus serotype 35 vectors

Sakurai F., Akitomo K., Kawabata K., Hayakawa T., Mizuguchi H.

Gene Ther., 14, 912-919 (2007)

Chimeric adenovirus 5/35 vector containing the clade C HIV gag gene induces a cross-reactive immune response against HIV

Xin K-Q., Sekimoto Y., Takahashi T., Mizuguchi H., Ichino M., Yoshida A., Okuda K.

Vaccine, 25, 3809-3815 (2007)

Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer

Gao J-Q., Kanagawa N., Motomura Y., Yanagawa T., Sugita T., Hatanaka Y., Tani Y., Mizuguchi H., Tsutsumi Y., Mayumi T., Okada N., Nakagawa S.

Gene Ther., 14, 491-502 (2007)

Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells

Yamashita M., Ino A., Kawabata K., Sakurai F., Mizuguchi H.

Int. J. Cancer, 121, 1690-1696 (2007)

Fiber-modified adenovirus vectors containing the TAT peptide derived from human immunodeficiency virus in the fiber knob have efficient gene transfer activity

Kurachi S., Tashiro K., Sakurai F., Sakurai H., Kawabata K., Yayama K., Okamoto H., Nakagawa S., Hayakawa T., Mizuguchi H.

Gene Ther., 14, 1160-1165 (2007)

Positive and negative regulation of adenovirus infection by CAR-like soluble protein, CLSP

Kawabata K., Tashiro K., Sakurai F., Osada N., Kusuda J., Hayakawa T., Yamanishi K., Mizuguchi H.

Gene Ther., 14, 1199-1207 (2007)

Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors

Yamaguchi T.#, Kawabata K.#, Koizumi N., Sakurai F., Nakashima K., Sasaki T., Okada N, Mizuguchi H. #These authors equally contributed to this work.

Hum. Gene Ther., 18, 753-762 (2007)

Targeted-delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells

Xin H., Kanehira M., Mizuguchi H., Hayakawa T., Kikuchi T., Nukiwa T., Saijo Y.

Stem Cells, 25, 1618-1626 (2007)

Adenovirus vectors composed of subgroup B adenoviruses

Sakurai F., Kawabata K., Mizuguchi H.

Curr. Gene Ther., 7, 229-238 (2007)

Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys

Someya K., Xin K-Q., Ami Y., Izumi Y., Mizuguchi H., Ohta S., Yamamoto N., Honda M., Okuda K.

Virology, 367, 390-397 (2007)

Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration

Gao J-Q., Eto Y., Yoshioka Y., Sekiguchi F, Kurachi S., Morishige T., Yao X., Watanabe H., Asavatanabodee R., Sakurai F., Mizuguchi H., Okada Y., Mukai Y., Tsutsumi Y., Mayumi T., Okada N., Nakagawa S.

J. Control. Release, 122, 102-110 (2007)

Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells

Murakami S.#, Sakurai F.#, Kawabata K., Okada N., Fujita T., Yamamoto A., Hayakawa T., Mizuguchi H. #These authors equally contributed to this work.

Gene Ther., 14, 1525-1533 (2007)

TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection

Yao X., Yoshioka Y., Eto Y., Morishige T., Okada Y., Mizuguchi H., Mukai Y., Okada N., Nakagawa S.

Biochem. Biophys. Res. Commun., 362, 419-424 (2007)

Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells

Kanehira M., Xin H., Hoshino K., Maemondo M., Mizuguchi H., Hayakawa T., Matsumoto K., Nakamura T., Nukiwa T., Saijo Y.

Cancer Gene Ther., 14, 894-903 (2007)

Role of a novel protein, CAR-like soluble protein (CLSP), in adenovirus infection

Kawabata K.

Yakugaku Zasshi, 127, 1091-1096 (2007)

アデノウイルスベクター開発の最前線

水口裕之

バイオテクノロジージャーナル, 羊土社, 7, 168-173 (2007)

改良型アデノウイルスベクターを用いた各種幹細胞への遺伝子デリバリー

川端健二, 櫻井文教, 水口裕之

Drug Delivery System, 日本DDS学会, 22, 148-154 (2007)

各種幹細胞への高効率遺伝子導入法の開発とその応用

川端健二

Drug Delivery System, 日本DDS学会, 22, 668-669 (2007)

アデノウイルスベクター

水口裕之, 早川堯夫

バイオ医薬品の開発と品質・安全性確保, エル・アイ・シー, 563-577 (2007)

遺伝子治療用医薬品の品質,安全性等の確保

早川堯夫, 前田大輔, 水口裕之

バイオ医薬品の開発と品質・安全性確保, エル・アイ・シー, 551-562 (2007)

大阪大学大学院 薬学研究科 分子生物学分野 

〒565-0871 大阪府吹田市山田丘1-6 大阪大学 大学院薬学研究科・薬学部 1号館 4階

TEL: 06-6879-8185 FAX: 06-6879-8187

Copyright© Laboratory of Biochemistry and Molecular Biology, Graduate School and School of Pharmaceutical Sciences, Osaka University

directed by Prof. Hiroyuki Mizuguchi

  • 分子生物学分野 | 阪大 | 薬学 | 生化 twitter
bottom of page